✦ LIBER ✦

Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation

✍ Scribed by Chia-Yen Dai; Ming-Lung Yu; Ming-Yen Hsieh; LI-Po Lee; Nai-Jen Hou; Jee-Fu Huang; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jun-Fa Tsai; Wen-Yu Chang; Wan-Long Chuang

Book ID: 111237740
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 138 KB
Volume: 27
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2007.01565.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to lamivudine therapy in chroni

Response to lamivudine therapy in chronic hepatitis B patients in Bangladesh

✍ Mobin Khan; A.K.M.Khorshed Alam; Salimur Rahman; Golam Azam; Nooruddin Ahmad 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Determinants of early mortality in patie

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy

✍ Robert J. Fontana; Hie-Won L. Hann; Robert P. Perrillo; John M. Vierling; Theres 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

515 Non-response and resistance to adefo

515 Non-response and resistance to adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ A. Valdes; M. Buti; R. Jardi; E. Rodriguez-Frias; M. Schaner; R. Esteban; J. Gua 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Serum cytokine levels in patients with c

Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy

✍ Younhee Park; Yongjung Park; Kwang-Hyub Han; Hyon-Suk Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract __Background__: Cytokines are known to play critical roles in the pathogenesis of chronic hepatitis B (CHB). However, the relationship between cytokines and treatment responses to drugs for CHB is not clearly defined yet. We measured the serum cytokine levels of interleukin (IL)‐1α, IL‐

Adefovir dipivoxil added to ongoing lami

Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B

✍ T. Vassiliadis; N. Nikolaidis; O. Giouleme; K. Tziomalos; N. Grammatikos; K. Pat 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

[491] EARLY MORTALITY AND RESPONSES IN N

[491] EARLY MORTALITY AND RESPONSES IN NONCIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS

✍ C.Y. Dai; M.L. Yu; N.T. Hou; M.Y. Hsieh; L.P. Lee; J.F. Huang; Z.Y. Lin; S.C. Ch 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 147 KB